fda compounding semaglutide update The is proposing the removal of three GLP-1 drugs from the 503B bulks list of active ingredients that outsourcing facilities can use to make compounded medicines, the agency announced on Thursday GLP-1 Medications – FDA Guidance

Is there a sex-shift in prevalence of allergic rhinitis and comorbid asthma from childhood to adulthood

Direct human use, including taking orally and injection and clinical use are forbidden.

Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome

a low ratio decreases IL-12 secretion which favors a Th2 response pattern over Th1 (a condition typically associated with chronic inflammation), while an elevated ratio favors a Th1 response (Brundu et al., 2016

Hydration, Upgraded: Smarter Ingredients for Smarter Performance Research shows that properly formulated hydration products improve fluid retention, exercise capacity, and reduce fatigue (3, 10)